Xencor | XNCR - Operating Profit


Xencor reported $-36.6M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Amgen USD 4.61B 777M Jun/2026
Arrowhead Research USD -170.09M 28.83M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
Biogen USD -243.8M 758.1M Jun/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Cytokinetics USD -179.17M 2.05M Jun/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
J&J USD 7.48B 860M Jun/2026
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
MacroGenics USD -33.44M 21.34M Mar/2026
Merck USD 840M 2.72B Jun/2026
Novartis USD 4.75B 515M Jun/2026
Pfizer USD 667M 4.32B Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Xencor USD -36.6M 41.26M Jun/2026